Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc.
Inmune Bio, Inc.
Stemline Therapeutics, Inc.
Eisai Inc.
Inmune Bio, Inc.
TVAX Biomedical
TVAX Biomedical
Takeda
DNAtrix, Inc.
AbbVie
BBB-Therapeutics B.V.
Neurologix, Inc.